Dawn Halkuff

Dawn Halkuff

Director/Miembro de la Junta en XERIS BIOPHARMA HOLDINGS, INC. .

Fortuna: 767 554 $ al 31/05/2026

55 años
Consumer Services
Health Technology
Commercial Services

Perfil

Dawn Halkuff currently works at Society For Women's Health Research, as Director from 2017 and Xeris Biopharma Holdings, Inc., as Independent Non-Executive Director from 2021.
Ms. Halkuff also formerly worked at Ideal Protein of America, Inc., as Chief Executive Officer & Director from 2021 to 2024, Laboratoires C.O.P., Inc., as Chief Executive Officer, Xeris Pharmaceuticals, Inc., as Independent Non-Executive Director from 2018 to 2021, Pfizer Inc., as Senior Vice President-Consumer Healthcare from 2010 to 2016, WW International, Inc., as Head-Global Innovation from 2005 to 2010, WW International, Inc., as Head-Global Innovation, and TherapeuticsMD, Inc., as Chief Commercial Officer from 2016 to 2021.
Ms. Halkuff received her Masters Business Admin degree in 1997 from The Pennsylvania State University and undergraduate degree in 1992 from the University of Connecticut.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
04/06/2026 124.603 ( 0,07 % ) 767 554 $ 31/05/2026

Cargos activos de Dawn Halkuff

EmpresasCargoInicio
XERIS BIOPHARMA HOLDINGS, INC. Director/Miembro de la Junta 05/10/2021
Director/Miembro de la Junta 13/07/2017

Antiguos cargos conocidos de Dawn Halkuff.

EmpresasCargoFin
Director Ejecutivo 01/03/2024
Director Ejecutivo 01/01/2024
Director/Miembro de la Junta 05/10/2021
THERAPEUTICSMD, INC. Corporate Officer/Principal 01/09/2021
PFIZER INC. Corporate Officer/Principal 01/10/2016
Ver el detalle de la experiencia de Dawn Halkuff.

Formación de Dawn Halkuff.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

80

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas10

Health Technology

Consumer Services

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Consumer Services

Consumer Services

Health Technology

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN